Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Neurology, Division of Neurointerventional Surgery, University of Iowa, Iowa City, Iowa, USA.
J Neurointerv Surg. 2020 Oct;12(10):1028-1032. doi: 10.1136/neurintsurg-2020-015827. Epub 2020 May 18.
To compare the computed tomography perfusion (CTP) outcomes derived from two commercial CTP processing software and evaluate their concordance in terms of eligibility for mechanical thrombectomy (MT) in acute ischemic stroke (AIS), based on DEFUSE III criteria.
A total of 118 patients (62 patients in the MT group and 56 patients in the non-MT (NMT) group) were included. Volumetric perfusion outputs were compared between Syngo.via (package A) and RAPID (package B). Influence on proceeding or not-proceeding with MT was based on DEFUSE III imaging eligibility criteria.
Median core infarct/hypoperfusion volumes were 12.3/126 mL in the MT group and 7.7/29.3 ml in the NMT group with package A and 10.5/138 mL and 1.9/24.5 mL with package B, respectively. In the MT group (n=62), concordant perfusion results in terms of patient triage were noted in all but two cases. Of these, one patient would not have qualified (low ASPECTS), while the other qualified based on package A results. For the NMT group (n=56), there was discordance in terms of MT eligibility in seven cases. However, none of these patients qualified for MT based on DEFUSE III criteria.
Both perfusion softwares showed high concordance in correctly triaging patients in the MT versus NMT groups (110/118, 93.2%), which further improved when all DEFUSE III imaging criteria were considered (117/118, 99.1%). The core/hypoperfusion volumes in the NMT group and core infarct volumes in the MT groups were comparable. The hypoperfusion volumes in the MT group varied slightly but did not affect triage between groups.
本研究旨在比较两种商业化 CT 灌注(CTP)处理软件得出的 CTP 结果,并基于 DEFUSE III 标准评估其在急性缺血性脑卒中(AIS)患者中接受机械取栓(MT)治疗的入选率方面的一致性。
共纳入 118 例患者(MT 组 62 例,非 MT(NMT)组 56 例)。比较 Syngo.via(软件 A)和 RAPID(软件 B)的容积灌注输出结果。根据 DEFUSE III 影像学入选标准,评估对 MT 治疗的影响。
MT 组(n=62)中,核心梗死体积/低灌注体积在软件 A 中分别为 12.3/126 ml 和 10.5/138 ml,在软件 B 中分别为 12.3/126 ml 和 10.5/138 ml;NMT 组(n=56)中,软件 A 和软件 B 分别为 7.7/29.3 ml 和 1.9/24.5 ml 和 2.9/24.5 ml。在 MT 组中,所有患者均存在一致的灌注结果,仅两例患者除外。其中一例患者 ASPECTS 评分较低而不符合入选标准,另一例患者软件 A 结果符合入选标准。在 NMT 组中,有 7 例患者的 MT 入选率不一致。然而,根据 DEFUSE III 标准,这些患者均不符合 MT 入选标准。
软件 A 和软件 B 均能在 MT 组与 NMT 组中正确地对患者进行分诊,一致性较高(110/118,93.2%)。当所有 DEFUSE III 影像学标准均被考虑时,一致性进一步提高(117/118,99.1%)。NMT 组的核心/低灌注体积和 MT 组的核心梗死体积相当。MT 组的低灌注体积略有差异,但不会影响两组间的分诊。